Patent assignee · US · COMPANY

Vitae Pharmaceuticals, LLC

86Patents
84Active
86Granted
53Portfolio score

Filing activity: Oct 7, 2005 → Sep 2, 2022 · 32 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8242111B2 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 Chemistry; Metallurgy 35 Active
US8138178B2 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 Chemistry; Metallurgy 33 Active
US8202857B2 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1 Chemistry; Metallurgy 22 Active
US8329897B2 Synthesis of inhibitors of 11β-hydroxysteroid dehydrogenase type 1 Chemistry; Metallurgy 19 Active
US8440658B2 Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 Chemistry; Metallurgy 18 Active
US9266886B2 Dihydropyrrolopyridine inhibitors of ROR-gamma Chemistry; Metallurgy 18 Active
US9481674B1 Dihydropyrrolopyridine inhibitors of ROR-gamma Chemistry; Metallurgy 14 Active
US9868748B2 Thiazolopyrrolidine inhibitors of ROR- γ Chemistry; Metallurgy 13 Active
US8981112B2 Inhibitors of β-secretase Chemistry; Metallurgy 13 Active
US9796710B2 Dihydropyrrolopyridine inhibitors of ROR-gamma Human Necessities 12 Active
US9663515B2 Dihydropyrrolopyridine inhibitors of ROR-gamma Chemistry; Metallurgy 12 Active
US10047085B2 Dihydropyrrolopyridine inhibitors of ROR-gamma Chemistry; Metallurgy 12 Active
US9624217B2 Dihydropyrrolopyridine inhibitors of ROR-gamma Chemistry; Metallurgy 12 Active
US8450308B2 Inhibitors of beta-secretase Chemistry; Metallurgy 11 Active
US10087184B2 Dihydropyrrolopyridine inhibitors of RORγ Human Necessities 10 Active
US10399976B2 Dihydropyrrolopyridine inhibitors of ROR-gamma Chemistry; Metallurgy 9 Active
US8633212B2 Inhibitors of beta-secretase Chemistry; Metallurgy 8 Active
US10683302B2 Inhibitors of the menin-MLL interaction Chemistry; Metallurgy 6 Active
US10301261B2 Substituted indoles as modulators of ROR-gamma Chemistry; Metallurgy 6 Active
US8598163B2 Derivatives of [1,3]Oxazin-2-one useful for the treatment of metabolic diseases such as lipid disorders Chemistry; Metallurgy 6 Active
US7754737B2 Diaminoalkane aspartic protease inhibitors Emerging Cross-Sectional Technologies 5 Expired
US8569292B2 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 Chemistry; Metallurgy 5 Active
US7872028B2 Diaminopropanol renin inhibitors Chemistry; Metallurgy 5 Active
US8592410B2 Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1 Chemistry; Metallurgy 4 Active
US9006245B2 Liver X receptor modulators Chemistry; Metallurgy 4 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.